Comparing the effects of atomised(intranasal aerosol) and nebulised (respiratory)droplets forms of dexmedetomidine to sedate children of upto 8 years of age undergoing cataract surgery
Phase 3
- Conditions
- Health Condition 1: H25-H28- Disorders of lens
- Registration Number
- CTRI/2019/02/017671
- Lead Sponsor
- Ankur Luthra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All ASA I and II children aged 1 to 8 years scheduled for cataract surgery under general anaesthesia
Exclusion Criteria
Children with cardiac anomalies, upper respiratory tract infection, liver disease, seizures or an acute medical condition, increased intracranial pressure, or a history of dexmedetomidine allergy will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of effectiveness of atomised vs nebulised dexmedetomidine as pre-medication in children undergoing cataract surgery in terms of parental separation score Emotional State Scale-4.Timepoint: 30 min after intervention
- Secondary Outcome Measures
Name Time Method To Compare <br/ ><br>1. Mean time of onset of adequate sedation score <br/ ><br>2. Success rate of IV cannulation <br/ ><br>3. Parental separation <br/ ><br>4. Mask acceptance <br/ ><br>5. Haemodynamic changes <br/ ><br>6. Wake up behaviour <br/ ><br>Timepoint: 30 min after intervention